NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 1100 coverBiogerontology: Mechanisms and Interventions Volume 1100 published April 2007
Ann. N.Y. Acad. Sci. 1100: 241–245 (2007). doi: 10.1196/annals.1395.025
Copyright © 2007 by the New York Academy of Sciences
description | purchase volume purchase this volume

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via Google Scholar
Google Scholar
Articles by OLGUN, A.
Articles by AKMAN, S.
Search for Related Content
PubMed
PubMed Citation
Articles by OLGUN, A.
Articles by AKMAN, S.

Part III. Molecular and Cellular Aging

Mitochondrial DNA-Deficient Models and Aging

ABDULLAH OLGUNa AND SERIF AKMANa

a Department of Biochemistry and Clinical Biochemistry, Gülhane School of Medicine, 06018 Etlik, Ankara, Turkey

Key Words: aging • longevity • mitochondrial DNA • model

Address for correspondence: Abdullah Olgun, M.D., Department of Biochemistry and Clinical Biochemistry, Gülhane School of Medicine, 06018 Etlik, Ankara, Turkey. Voice: +90-312-2912130; fax: +90-312-3043300.  aolgun{at}yahoo.com

Human mitochondrial DNA (mtDNA) encodes 13 subunits of oxidative phosphorylation (OXPHOS) enzyme complexes I, III, IV, and V except complex II. MtDNA is more sensitive to oxidative damage than nuclear DNA. MtDNA defects are involved in many pathologies including aging. Several mtDNA-deficient cell culture, yeast, and animal models were generated to study the role of mtDNA in many physiological processes. Ethidium bromide (EB), an agent that is known to inhibit mtDNA replication with a negligible effect on nuclear DNA, is generally used to generate mtDNA-deficient models. The antibiotics chloramphenicol and doxycycline, which were known to inhibit mitochondrial translation, were also used to generate the same phenotype. Cultured mtDNA-deficient cells need uridine and pyruvate to survive. At the organismal level, uridine can be supplemented, but pyruvate supplementation can cause a worser phenotype because of lactic acidosis. In C. elegans, EB, when used during larval development, increases life span, but decreases, when used after the beginning of adult stage. This should be kept in mind since mitochondria-related genes are generally detected in genome-wide screening studies for longevity. We believe that conditional knockout studies need to be carried out for these genes after reaching adulthood. MtDNA mutator mouse did not show an increase of free radical production. Therefore, the downstream phenomena to mtDNA defects are likely ineffective pyrimidine synthesis (dihydroorotate dehydrogenase, DHODH, needs a functional respiratory chain) and excess NADH (decreased NAD pool) in addition to free radicals.






footerLeft footerRight